Representative photo by Ketut Subiyanto/Pexels

Ashley M Hopkins, Flinders University

You may have heard the buzz about ChatGPT, a type of chatbot that uses artificial intelligence (AI) to write essays, turn computer novices into programmers and help people communicate.

ChatGPT might also have a role in helping people make sense of medical information.

Although ChatGPT won’t replace talking to your doctor any time soon,
our new research shows its potential to answer common questions about cancer.

Here’s what we found when we asked the same questions to ChatGPT and Google. You might be surprised by the results.

What’s ChatGPT got to do with health?

ChatGPT has been trained on massive amounts of text data to generate conversational responses to text-based queries.

ChatGPT represents a new era of AI technology, which will be paired with search engines, including Google and Bing, to change the way we navigate information online. This includes the way we search for health information.

For instance, you can ask ChatGPT questions like “Which cancers are most common?” or “Can you write me a plain English summary of common cancer symptoms you shouldn’t ignore”. It produces fluent and coherent responses. But are these correct?

We compared ChatGPT with Google

Our newly published research compared how ChatGPT and Google responded to common cancer questions.

These included simple fact-based questions like “What exactly is cancer?” and “What are the most common cancer types?”. There were also more complex questions about cancer symptoms, prognosis (how a condition is likely to progress) and side effects of treatment.

To simple fact-based queries, ChatGPT provided succinct responses similar in quality to the feature snippet of Google. The feature snippet is “the answer” Google’s algorithm highlights at the top of the page.

While there were similarities, there were also broad differences between ChatGPT and Google replies. Google provided easily visible references (links to other websites) with its answers. ChatGPT gave different answers when asked the same question multiple times.

Woman in lounge room coughing into fist
Is coughing a sign of lung cancer? Photo: Shutterstock

We also evaluated the slightly more complex question: “Is coughing a sign of lung cancer?”.

Google’s feature snippet indicated a cough that does not go away after three weeks is a main symptom of lung cancer.

But ChatGPT gave more nuanced responses. It indicated a long-standing cough is a symptom of lung cancer. It also clarified that coughing is a symptom of many conditions, and that a doctor would be required to get a proper diagnosis.

Our clinical team thought these clarifications were important. Not only do they minimise the likelihood of alarm, they also provide users clear directions on actions to take next – see a doctor.

How about even more complex questions?

We then asked a question about side-effects to a specific cancer drug: “Does pembrolizumab cause fever and should I go to the hospital?”.

We asked ChatGPT this five times and received five different responses. This is due to randomness built into ChatGPT, which may help communicate in a near human-like way, but will throw up multiple responses to the same question.

All five responses recommended speaking to a health-care professional. But not all said this was urgent or clearly defined how potentially serious this side-effect was. One response said fever was not a common side effect but did not explicitly say it could occur.

In general, we graded the quality of responses from ChatGPT to this question as poor.

Woman on sofa with towel one forehead and thermometer in hand
Does pembrolizumab cause fever and should I go to the hospital? Photo: Shutterstock

This contrasted with Google, which did not generate a featured snippet, likely due to the complexity of the question.

Instead, Google relied on users to find the necessary information. The first link directed them to the manufacturer’s product website. This source clearly indicated people should seek immediate medical attention if there was any fever with pembrolizumab.

What next?

We showed ChatGPT doesn’t always provide clearly visible references for its responses. It gives varying answers to a single given query and it is not kept up-to-date in real time. It can also produce incorrect responses in a confident-sounding manner.

Bing’s new chatbot, which is different to ChatGPT and was released since our study, has a much clearer and more reliable process to outline reference sources and it aims to keep as up-to-date as possible. This shows how quickly this type of AI technology is developing and that the availability of progressively more advanced AI chatbots is likely to grow substantially.

However, in the future, any AI used as a health-care virtual assistant will need to be able to communicate any uncertainty about its responses rather than make up an incorrect answer, and consistently produce reliable responses.

We need to develop minimum quality standards for AI interventions in health care. This includes ensuring they generate evidence-based information.

We also need to assess how AI virtual assistants are implemented to make sure they improve people’s health and don’t have any unexpected consequences.

There’s also the potential for medically focused AI assistants to be expensive, which raises questions of equity and who has access to these rapidly developing technologies.

Last of all, health-care professionals need to be aware of such AI innovations to be able to discuss their limitations with patients.


Ganessan Kichenadasse, Jessica M. Logan and Michael J. Sorich co-authored the original research paper mentioned in this article.The Conversation

Ashley M Hopkins, NHMRC Investigator Fellow, leader of the Clinical Cancer Epidemiology Lab, Flinders University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Subscribe to our Newsletter


The Conversation
About The Conversation

-

The Conversation, a collaboration between academics and journalists, is a leading publisher of research-based news and analysis.